Hi Ben,
That is a good question. In this particular study, we can identify possible biomarkers only if they "move" with changing fatigue. So, as you are suggesting, if the fatigue does not fluctuate, then we cannot conduct the analyses. The pattern recognition algorithms can't work without movement.
There are two scenarios that could work for individuals with high and unwavering fatigue severity. The first possibility is that the same analytes are driving fatigue in those individuals, but the system is elevated every day. In that case, we will first make sure we have the handful of most important markers in the fluctuating group, and then we will see if those markers are elevated consistently in the non-fluctuating group. If so, we would have a consistent story to work with. The other possibility is that the individuals with high and unwavering fatigue have a different driver of fatigue. In that case, we will identify those people based on their fatigue and then see if any baseline blood measures (we take lots of them) predict who is in that group. That will give us information about what is wrong.
The downside is that those analyses are cross-sectional, and require more participants to complete the study before we can do the statistics. If someone has varying fatigue, we can do analyses just on that one individual. If they have invariable fatigue, we need a large group. But we are running 40 people every year and so it won't take too long to do the analyses that need to be done. Probably by the end of this year.
Another important thing is that we have a budget to run some people who have ME/CFS so severe that they can't come to the laboratory. We will be looking very closely to see whether they have a different form of ME/CFS, or a more severe case of ME/CFS (based on the blood results). But the bottom line is that it is clear from the analyses that many participants have high and consistent fatigue. We will not forget about those participants. We will be exploring the blood results in everyone, and will try to assign everyone in a meaningful physiologic group regardless of their symptom presentation, to suggest targeted treatments.
Jarred